These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7330645)

  • 21. [The dosage of important antibiotics and tuberculostatics in renal insufficiency].
    Höffler D
    Internist (Berl); 1981 Oct; 22(10):601-6. PubMed ID: 7028662
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antibacterial chemotherapy in renal failure].
    Briedigkeit H
    Z Urol Nephrol; 1983 May; 76(5):349-52. PubMed ID: 6880421
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease.
    Teichert J; Tuemmers T; Achenbach H; Preiss C; Hermann R; Ruus P; Preiss R
    J Clin Pharmacol; 2005 Mar; 45(3):313-28. PubMed ID: 15703366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of thalidomide in patients with impaired renal function and while on and off dialysis.
    Eriksson T; Höglund P; Turesson I; Waage A; Don BR; Vu J; Scheffler M; Kaysen GA
    J Pharm Pharmacol; 2003 Dec; 55(12):1701-6. PubMed ID: 14738599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Renal insufficiency and drug metabolism].
    Balant LP
    Therapie; 1987; 42(4):393-7. PubMed ID: 3686475
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
    Vanholder R; Camez A; Veys N; Van Loo A; Dhondt AM; Ringoir S
    Thromb Haemost; 1997 Apr; 77(4):650-5. PubMed ID: 9134637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased melatonin nocturnal concentrations in hemodialyzed patients.
    Karasek M; Szuflet A; Chrzanowski W; Zylinska K; Swietoslawski J
    Neuro Endocrinol Lett; 2005 Dec; 26(6):653-6. PubMed ID: 16380697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.
    Chen N; Lau H; Kong L; Kumar G; Zeldis JB; Knight R; Laskin OL
    J Clin Pharmacol; 2007 Dec; 47(12):1466-75. PubMed ID: 17954615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic-pharmacodynamic modelling of oxprenolol in man using continuous non-invasive blood pressure monitoring.
    Koopmans R; Oosterhuis B; Karemaker JM; Wemer J; van Boxtel CJ
    Eur J Clin Pharmacol; 1988; 34(4):395-400. PubMed ID: 3402525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initiation and maintenance of beta-blockade with intravenous oxprenolol.
    Silke B; John VA; Calvert RT; Taylor SH
    Eur J Clin Pharmacol; 1983; 24(1):7-14. PubMed ID: 6832204
    [No Abstract]   [Full Text] [Related]  

  • 31. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation between plasma concentrations and cardiovascular effects of oral oxprenolol in man.
    Brunner L; Imhof P; Jack D
    Eur J Clin Pharmacol; 1975; 8(1):3-9. PubMed ID: 786674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics, metabolism and excretion of intravenous [l4C]-palonosetron in healthy human volunteers.
    Stoltz R; Parisi S; Shah A; Macciocchi A
    Biopharm Drug Dispos; 2004 Nov; 25(8):329-37. PubMed ID: 15378559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Kidney function in hypertensive patients with chronic renal failure treated with the dual eliminated ACE-inhibitor spirapril].
    Haufe CC; Sierakowski B; Jansa U; Stein G
    Med Klin (Munich); 1994 Aug; 89(8):416-20. PubMed ID: 7968874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics of nisoldipine in hypertensive patients with normal and mild to moderate impaired renal function.
    Shionoiri H; Minamisawa K; Masumori S; Satta H; Minamisawa M; Takizawa T; Jinno Y; Takeda K; Nagasawa T; Takasaki I
    Arzneimittelforschung; 1995 Jul; 45(7):785-9. PubMed ID: 8573223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients.
    Kirby WM; De Maine JB; Serrill WS
    Postgrad Med J; 1971 Feb; 47():Suppl:41-6. PubMed ID: 5556189
    [No Abstract]   [Full Text] [Related]  

  • 38. [Problems of glycoside therapy in kidney insufficiency and uremia].
    Rupp M; Brass H; Glöckler D
    Med Welt; 1981 Jan; 32(4):115-22. PubMed ID: 7207142
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacokinetics and biotransformation of oxametacine in healthy volunteers (author's transl)].
    Vergin H; Ferber H; Brunner F; Kukovetz WR
    Arzneimittelforschung; 1981; 31(3):513-8. PubMed ID: 7194675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple inverse isotope dilution assay for oxprenolol and nine metabolites in biological fluids.
    Dieterle W; Faigle JW
    J Chromatogr; 1983 Apr; 259(2):301-10. PubMed ID: 6343407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.